144 related articles for article (PubMed ID: 23991961)
1. Prognostic value of MMP-9 in ovarian cancer: a meta-analysis.
Li LN; Zhou X; Gu Y; Yan J
Asian Pac J Cancer Prev; 2013; 14(7):4107-13. PubMed ID: 23991961
[TBL] [Abstract][Full Text] [Related]
2. Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis.
Liu C
Clin Exp Med; 2016 Aug; 16(3):375-82. PubMed ID: 26123901
[TBL] [Abstract][Full Text] [Related]
3. The expression of tumor-derived and stromal-derived matrix metalloproteinase 2 predicted prognosis of ovarian cancer.
Fu Z; Xu S; Xu Y; Ma J; Li J; Xu P
Int J Gynecol Cancer; 2015 Mar; 25(3):356-62. PubMed ID: 25695542
[TBL] [Abstract][Full Text] [Related]
4. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis.
Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY
Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis.
Song J; Su H; Zhou YY; Guo LL
Asian Pac J Cancer Prev; 2013; 14(3):1615-21. PubMed ID: 23679245
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of MMP-2 for patients with ovarian epithelial carcinoma: a systematic review and meta-analysis.
Jia H; Zhang Q; Liu F; Zhou D
Arch Gynecol Obstet; 2017 Mar; 295(3):689-696. PubMed ID: 27995372
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis.
Li CY; Yuan P; Lin SS; Song CF; Guan WY; Yuan L; Lai RB; Gao Y; Wang Y
Tumour Biol; 2013 Apr; 34(2):735-41. PubMed ID: 23269605
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of matrix metalloproteinase-9 in gastric cancer: a meta-analysis.
Chen J; Chen LJ; Zhou HC; Yang RB; Lu Y; Xia YL; Wu W; Hu LW
Hepatogastroenterology; 2014; 61(130):518-24. PubMed ID: 24901174
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis.
Desmeules P; Trudel D; Turcotte S; Sirois J; Plante M; Grégoire J; Renaud MC; Orain M; Têtu B; Bairati I
Hum Pathol; 2015 May; 46(5):739-45. PubMed ID: 25771900
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic values of MMP-9 expression in ovarian cancer: A study based on bioinformatics analysis and meta-analysis.
Liu C; Shen Y; Tan Q
Int J Biol Markers; 2023 Mar; 38(1):15-24. PubMed ID: 36448239
[TBL] [Abstract][Full Text] [Related]
13. [Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour].
Gao GL; Liu LD; Zou XS; Chen WX
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):34-8. PubMed ID: 17331419
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.
Hu X; Li D; Zhang W; Zhou J; Tang B; Li L
Arch Gynecol Obstet; 2012 Dec; 286(6):1537-43. PubMed ID: 22832979
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of matrix metalloproteinase-9 (gelatinase-B) expression in epithelial ovarian tumors.
Ozalp S; Tanir HM; Yalcin OT; Kabukcuoglu S; Oner U; Uray M
Eur J Gynaecol Oncol; 2003; 24(5):417-20. PubMed ID: 14584660
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: a meta-analysis of observational studies.
Lee JY; Myung SK; Song YS
Gynecol Oncol; 2013 Jun; 129(3):613-9. PubMed ID: 23422504
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between bacterial L-form infection, expression of HIF-1α/MMP-9 and vasculogenic mimicry in epithelial ovarian cancer].
Yu L; Wu SW; Zhou L; Song WQ
Sheng Li Xue Bao; 2012 Dec; 64(6):657-65. PubMed ID: 23258329
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of platelet count in patients with ovarian cancer.
Zhou Q; Huang F; He Z; Zuo MZ
Climacteric; 2018 Feb; 21(1):60-68. PubMed ID: 29231068
[TBL] [Abstract][Full Text] [Related]
19. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
